SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001171843-18-005278
Filing Date
2018-07-23
Accepted
2018-07-23 08:02:40
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM F-3 ff3_072318.htm F-3 259653
2 EXHIBIT 5.1 exh_51.htm EX-5.1 26978
3 EXHIBIT 23.1 exh_231.htm EX-23.1 4123
4 GRAPHIC logo.jpg GRAPHIC 31935
5 GRAPHIC gkh.jpg GRAPHIC 19267
6 GRAPHIC pwc.jpg GRAPHIC 4683
  Complete submission text file 0001171843-18-005278.txt   368923
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: F-3 | Act: 33 | File No.: 333-226278 | Film No.: 18963620
SIC: 2834 Pharmaceutical Preparations